Bluefish wins tender in Germany

Bluefish Pharma GmbH received award for five products at a tender of Signal Iduna IKK health insurances in Germany. Bluefish is one of a total three pharmaceuticals companies that won the tender contract for the selected products, it is valid for two years and starts the 1st of November 2010. Signal Iduna IKK health insurances in Germany, covering in total 1.7 million people. The products in the contract are Alendronate, Metformin, Mirtazapine ODT, Sertralin and Simvastatin.

For more information contact,
Karl Karlsson, President & CEO Bluefish Pharmaceuticals
Tel. +46 8 519 11 600
Email: karl.karlsson@bluefishpharma.com

Åsa Axelsson, Deputy CFO Bluefish Pharmaceuticals
Tel. +46 8 519 11 600
Email: asa.axelsson@bluefishpharma.com

About Bluefish Pharmaceuticals
Bluefish Pharmaceuticals offers high quality, cost effective generic pharmaceuticals of great medical value to patients. The company was founded in 2005 with the ambition to create a pan-European pharmaceutical company with focus on product development, registration and marketing.
The company's product portfolio consists of 33 products, whereof 26 are approved in at least one European country, and another 7 are under registration. Bluefish has offices in Sweden, India, Austria, Germany, Italy, Hungary, Poland and the Netherlands.
www.bluefishpharma.com